Contemporary OB/GYN week in review: UTIs, HIV-1, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: UTIs, HIV-1, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, April 22 - Friday, April 26 2024), and click each link to read and watch anything you may have missed.
1.) FDA approves Pivya for treating uncomplicated UTIs
Explore the efficacy of Pivya (pivmecillinam; Utility Therapeutics) tablets in managing uncomplicated urinary tract infections in female adults, supported by controlled clinical trials and safety considerations.
Click here for the full article.
2.) FDA approves updated label for Biktarvy against HIV-1
Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Click here for the full article.
3.) Survey shows growing support for IVF coverage in US health care
A recent poll highlights increasing public demand for broader insurance coverage for in vitro fertilization, underscoring persistent barriers faced by millions without access to adequate fertility care.
Click here for the full article.
4.) Study finds antihypertensive treatment reduces uterine fibroids risk
A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Click here for the full article.
5.) Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Pap Talk S4E4: RFA and uterine fibroids with Dr. Jessica Shepherd
March 30th 2022In this episode of Pap Talk, Jessica Shepherd, MD, MBA, FACOG, deep dives into the benefits of utilizing radio frequency ablation (RFA) for treatment of uterine fibroids, available RFA devices, and disparities in the condition.
Listen
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Racial disparities based on delivery hospital quality reported
March 24th 2025A new study found that Black and American Indian birthing individuals in the United States are more likely to deliver at lower-quality hospitals than White patients, highlighting systemic health care inequities.
Read More
